NorthCrest Asset Manangement’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3M | Sell |
64,000
-3,070
| -5% | -$144K | 0.08% | 177 |
|
|
2025
Q1 | $4.09M | Sell |
67,070
-47,889
| -42% | -$2.92M | 0.12% | 150 |
|
|
2024
Q4 | $6.5M | Sell |
114,959
-39,374
| -26% | -$2.23M | 0.19% | 119 |
|
|
2024
Q3 | $7.99M | Sell |
154,333
-3,089
| -2% | -$160K | 0.24% | 108 |
|
|
2024
Q2 | $6.54M | Sell |
157,422
-3,291
| -2% | -$137K | 0.22% | 119 |
|
|
2024
Q1 | $8.72M | Buy |
160,713
+10,744
| +7% | +$583K | 0.3% | 99 |
|
|
2023
Q4 | $7.69M | Sell |
149,969
-12,082
| -7% | -$620K | 0.29% | 105 |
|
|
2023
Q3 | $9.41M | Buy |
162,051
+2,090
| +1% | +$121K | 0.38% | 85 |
|
|
2023
Q2 | $10.2M | Buy |
159,961
+1,787
| +1% | +$114K | 0.4% | 81 |
|
|
2023
Q1 | $11M | Buy |
158,174
+35,074
| +28% | +$2.43M | 0.46% | 74 |
|
|
2022
Q4 | $8.86M | Sell |
123,100
-24
| -0% | -$1.73K | 0.5% | 69 |
|
|
2022
Q3 | $8.75M | Buy |
123,124
+1,620
| +1% | +$115K | 0.47% | 78 |
|
|
2022
Q2 | $9.36M | Buy |
121,504
+2,052
| +2% | +$158K | 0.48% | 76 |
|
|
2022
Q1 | $8.72M | Buy |
119,452
+12,944
| +12% | +$945K | 0.41% | 88 |
|
|
2021
Q4 | $6.64M | Buy |
+106,508
| New | +$6.64M | 0.36% | 90 |
|